University of Sheffield researchers are pioneering ‘smart’ drug delivery systems, combining Cold Atmospheric Plasma with molecular imprinting. This innovation promises targeted chemotherapy for glioblastoma post-surgery, alongside new treatments for severe skin inflammation and fungal infections. The technology, funded by EPSRC, aims to precisely deliver drugs on demand, potentially revolutionizing medical treatments.
